Mankind Pharma Ltd (MANKIND) Stock Price & News

Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia

About Mankind Pharma Ltd

CEORajeev Juneja | Sheetal Arora

Employees20,5 мың

Founded1991

Headquarters-

SectorPharmaceutical industry

Websitemankindpharma.com

All values in INR	2025 ж. қыр.	2025 ж. жел.	2026 ж. нау.	2026 ж. мау.
Revenue	36,97 млрд	35,67 млрд	34,43 млрд	40,31 млрд
Cost of goods sold	10,62 млрд	9,78 млрд	11,71 млрд	10,98 млрд
Cost of revenue	10,62 млрд	9,78 млрд	11,71 млрд	10,98 млрд
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8,25 млрд	8,24 млрд	15,80 млрд	9,14 млрд
Operating expense	19,35 млрд	18,92 млрд	14,77 млрд	21,02 млрд
Total operating expenses	29,98 млрд	28,70 млрд	26,48 млрд	32,00 млрд
Operating income	7,00 млрд	6,97 млрд	7,95 млрд	8,30 млрд
Other non operating income	918,70 млн	727,50 млн	-2,31 млрд	450,00 млн
EBT including unusual items	6,24 млрд	5,09 млрд	6,59 млрд	7,69 млрд
EBT excluding unusual items	6,24 млрд	6,16 млрд	5,59 млрд	7,69 млрд
Income tax expense	1,04 млрд	951,20 млн	997,50 млн	1,95 млрд
Effective tax rate	16,64%	18,69%	15,13%	25,39%
Other operating expenses	8,88 млрд	8,46 млрд	-3,26 млрд	9,63 млрд
Net income	5,12 млрд	4,09 млрд	5,54 млрд	5,68 млрд
Net profit margin	13,84%	11,46%	16,10%	14,09%
Earnings per share	12,38	11,99	13,89	13,74
Interest and investment income	-	-	580,50 млн	-
Interest expense	-1,70 млрд	-1,57 млрд	-1,36 млрд	-1,10 млрд
Net interest expenses	-1,70 млрд	-1,57 млрд	-778,20 млн	-1,10 млрд
Depreciation and amortization charges	2,22 млрд	2,23 млрд	2,23 млрд	2,26 млрд
EBITDA	9,20 млрд	8,42 млрд	9,97 млрд	10,33 млрд
Gain or loss from assets sale	-	-	-	-

Ask anything